Archived Grant Opportunity View - GO6206
2023 Priority-driven Collaborative Cancer Research Scheme for funding commencing in 2024
The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.
PdCCRS applications will only be accepted if an application has been submitted to NHMRC’s Ideas Grants or Clinical Trials and Cohort Studies Grants schemes and a corresponding PdCCRS Questions application has been submitted to Cancer Australia via the Can-Grant portal.
PdCCRS applications will only be accepted from NHMRC-approved Administering Institutions. A list of NHMRC-approved Administering Institutions and NHMRC’s Administering Institution Policy are available on NHMRC’s website.
The PdCCRS adheres to the relevant Ideas Grants guidelines or the Clinical Trials and Cohort Studies Grants guidelines published by NHMRC, unless otherwise stated in this document.
An eligibility ruling may be made by Cancer Australia at any stage following the close of applications, including during the assessment period.
From $100,000.00 to $600,000.00
Applicants are required to complete and submit a grant application to the National Health and Medical Research Council (NHMRC) Ideas Grants or Clinical Trials and Cohort Studies Grants schemes via the NHMRC granting system, indicating that the application is to be considered for funding by Cancer Australia. Applicants are also required to complete a PdCCRS application via Cancer Australia’s CanGrant system.
Please note, PdCCRS applications are due to be submitted via Can-Grant by:
• 31 May 2023 for Ideas Grants (both Standard Project Grants and Early Career Researcher Project Grants).
• 6 September 2023 for Clinical Trials and Cohort Studies Grants.